<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01049152</url>
  </required_header>
  <id_info>
    <org_study_id>20090003173</org_study_id>
    <nct_id>NCT01049152</nct_id>
  </id_info>
  <brief_title>Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of different glycemic variations between the dialysis period and non-dialysis
      period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis
      methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal
      disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The
      investigators will evaluate also inflammation markers before and after the different
      hemodialysis methods.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>-Hemodialysis tolerability -Hypoglycemia numbers -Hyperglycemia numbers -Inflammation markers</measure>
    <time_frame>before and after each procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>variations of glycemia during the night; insulin-sensitivity</measure>
    <time_frame>at the beginning of the first hemodialysis and at the end of the second hemodialysis</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Diabetes</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>nondiabetic patients</arm_group_label>
    <description>nondiabetic patients with ESRD undergone hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diabetic patients</arm_group_label>
    <description>diabetic patients with ESRD undergone hemodialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Glucose Monitoring (CGM)</intervention_name>
    <description>CGM allocated one time for 3 days</description>
    <arm_group_label>nondiabetic patients</arm_group_label>
    <arm_group_label>diabetic patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        outpatients will undergo CGM at two different hemodialysis methods in a croos-over design.
        At the end of the study, it will evaluate inflammation markers intra-and inter-groups
        during the different hemodialysis methods.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with or without diabetes mellitus

          -  ESRD

          -  undergone hemodialysis

          -  males and females aged 50-80

        Exclusion Criteria:

          -  tumors

          -  chronic inflammation diseases

          -  AMI

          -  acute pulmonary diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Derosa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pavia- Fondazione IRCCS Policlinico San Matteo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Derosa, MD, PhD</last_name>
    <phone>+39 0382 522614</phone>
    <email>giuseppe.derosa@unipv.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pamela Maffioli, MD</last_name>
    <email>pamelamaffioli@hotmail.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Derosa, MD, PhD</last_name>
      <email>giuseppe.derosa@unipv.it</email>
    </contact>
    <contact_backup>
      <last_name>Pamela Maffioli, MD</last_name>
      <email>pamelamaffioli@hotmail.it</email>
    </contact_backup>
    <investigator>
      <last_name>Giuseppe Derosa, Md, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pamela Maffioli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2010</study_first_posted>
  <last_update_submitted>August 18, 2013</last_update_submitted>
  <last_update_submitted_qc>August 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Giuseppe Derosa</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Diabetes mellitus</keyword>
  <keyword>ESRD</keyword>
  <keyword>CGM</keyword>
  <keyword>Inflammation markers</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>Diabetic patients</keyword>
  <keyword>Nondiabetic patients</keyword>
  <keyword>All with ESRD</keyword>
  <keyword>All undergone hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

